You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 2, 2019

A Turning Point in Patent Invalidation in Vietnam?

Managing Intellectual Property

The possibility of invalidating a patent is clearly set out in Vietnam’s intellectual property laws. Historically, however, although thousands of patents are granted each year in Vietnam, the number of requests for invalidation has been extremely small. Nearly all of these cases have occurred in the context of patent disputes where the sanctioned party (in administrative measures) or defendant (in judicial measures) has been accused of patent infringement, and attempts to invalidate the patent in question as a defense mechanism, with the argument that if a patent is not valid, it cannot be infringed.

Patent disputes in Vietnam are handled by the courts and administrative enforcement agencies, while patent invalidation is handled by the National Office of Intellectual Property (NOIP). Although there are relatively clear provisions on invalidation in the law, the process of resolving such requests has rarely been straightforward. It can last for several years, and sometimes a final decision is never even issued. This creates a bottleneck, as the courts and enforcement bodies sometimes wait for the NOIP’s decision on invalidation before issuing a final conclusion on the dispute. If the process drags on indefinitely, patent owners will have difficulty enforcing their rights, while infringement continues unchecked.

Fortunately, the invalidation process may have entered a new era with the introduction of Circular No. 16/2016/TT-BKHCN (Circular 16), which was issued on June 30, 2016, but did not become effective until January 15, 2018. Circular 16 prescribes a clearer, stricter time limit for all steps in the patent invalidation process. It also clearly states that the NOIP, during the resolution process, will reexamine the patentability of the invention stated in the patent.

To see how these regulations are enforced in practice, we can look at a case that was resolved in October 2018 involving a request for partial invalidation of a patent in the field of medical devices. The patent was granted in October 2016, and soon after, the patent owner used it to fight a number of businesses importing infringing products into Vietnam. The manufacturer of the products then filed a request for invalidation of the patent in March 2017. After reviewing the opinions of the related parties, the NOIP issued a decision on partial invalidation of the patent in October 2018. This decision marks a number of important changes in comparison with past practice.

Processing time: The NOIP issued a formal decision 19 months after the request was filed. This could be considered “record-fast” by Vietnam’s previous standards and thus represents a great improvement, though it was notably still longer than the statutory timeline of 11 months under Circular 16.

Limitation of authority: In its decision, in addition to weighing the invalidation of the patent based on the requesting party’s specific grounds (a lack of novelty), the NOIP also proactively considered other aspects of the invention, such as whether it had the necessary inventive step.

While Circular 16 states that the NOIP will reexamine the patentability of the invention in invalidation proceedings, there is still debate over how much authority the NOIP should have in such a case: Should it be limited to considering whether it agreed or disagreed with the requesting party’s arguments, as in a civil lawsuit, or does it also have the right to consider other grounds not specifically raised by the parties? And if so, how should the procedures for considering these unsolicited contents be carried out? Should other stakeholders like the patent owner have the right to be informed and express their opinions in this process? This matter is a gap that remains unresolved by Circular 16, and will inevitably lead to more problems.

Independence of the patent office: Although the NOIP has made great strides in recent years, it is still not truly proactive and independent in many of its activities, including the patent examination process as well as the patent invalidation process. Specifically, in the examination of patent applications originating from foreign countries (which account for a majority of patent applications in Vietnam), the NOIP, rather than conducting an examination of the application itself, typically waits for the corresponding patents to be granted in developed countries by patent offices like the USPTO, EPO, or JPO, then relies on those results to determine whether to grant the patent in Vietnam. Similarly, in the process of considering the invalidation of a patent, the NOIP often relies on the outcomes of similar cases in developed countries.

In this case, however, it seems the NOIP showed a high degree of independence, making its decision based on its own analysis of patentability. This analysis was quite strict, and considerably different from the assessments of foreign patent agencies. This newfound independence may be a sign that the NOIP is ready to be truly proactive in assessing invalidation cases and ensuring a reasonable time limit for resolution, a positive development for future patent invalidation cases.

RELATED INSIGHTS​ 

September 14, 2026
Myanmar’s first-to-file trademark registration regime under the Trademark Law 2019—which became fully operational in April 2023—provides mark owners with enhanced legal protection compared with the country’s former system. Correspondingly, the current system imposes more rigorous statutory requirements for obtaining, maintaining, and enforcing rights in marks. In this first-to-file trademark registration system, however, evidence of use remains particularly significant, as it may establish acquired distinctiveness, support a claim that a mark is well-known, and strengthen the owner’s position in both registration and enforcement proceedings. Accordingly, it can be said that this framework is underpinned by three key concepts: distinctiveness, well-known status, and, importantly, use of the trademark. Trademark Distinctiveness Under the Trademark Law, signs that lack distinctiveness are generally ineligible for mark protection. These signs include generic terms, basic shapes, unstylized single letters or numerals, and signs that merely describe the kind, quality, quantity, intended purpose, value, geographical origin, production time, or other characteristics of the relevant goods or services. However, a mark that would otherwise be refused on distinctiveness or descriptiveness grounds may be registrable if it has acquired distinctiveness through its use prior to the filing date. To show this, the applicant must demonstrate that the mark became distinctive to relevant consumers through continuous, exclusive, and good-faith use in trade within Myanmar. The burden of proving acquired distinctiveness rests with the mark owner. Accordingly, sufficient evidence demonstrating both use of the mark and the level of consumer recognition attained should be prepared in advance. Well-Known Mark Criteria Myanmar’s Trademark Rules, which govern the substantive examination of mark registration applications, establish criteria for determining well-known marks, aligned with international standards. Where an applicant claims well-known status—whether to overcome a refusal on relative grounds or to oppose a third party’s registration—the registrar will assess the claim based on the following
September 14, 2026
On August 23, 2026, Vietnam’s National Assembly passed Law No. 11/2026/QH16, amending the country’s Customs Law with effect from March 1, 2027. The amendments represent a substantial reform of Vietnam’s customs-based intellectual property enforcement regime. The reforms come amid considerable external pressure. In its 2026 Special 301 review, the US Trade Representative (USTR) designated Vietnam a “priority foreign country,” citing widespread counterfeiting, weak border enforcement, limited ex officio customs powers, and the absence of controls over goods in transit. Vietnam’s legislative response signals a commitment to bringing its border enforcement practices into line with international expectations. For IP rights holders operating in or through Vietnam, the amended law introduces several tools that substantially strengthen enforcement options at the border. Closing the Transit Gap One of the most consequential amendments is the extension of IP-related customs enforcement to goods in transit. Previously, Vietnam’s customs regime applied IP controls only to goods being imported or exported, a gap the USTR had specifically identified as enabling infringing goods to pass through Vietnamese ports with impunity. Vietnam’s geographic position as a logistics hub for Southeast Asia means that substantial volumes of goods transit its ports and free-trade zones. Extending enforcement to cover these shipments brings Vietnam closer to the standard set by the EU’s customs enforcement regulation and addresses a longstanding concern of multinational brand owners whose goods are frequently counterfeited in the region. Strengthened Suspension and Ex Officio Powers The amended law introduces a dual-track suspension mechanism (Article 73(2)). Customs authorities will suspend clearance upon request by an IP rights holder (or authorized representative) who provides evidence of IP ownership, evidence of infringement, and a financial guarantee. Customs can now proactively suspend clearance on an ex officio basis if, during inspection and monitoring, they discover “clear grounds” to suspect that imported, exported,
September 7, 2026
Indonesia’s Constitutional Court (Mahkamah Konstitusi) has reinstated a key provision limiting pharmaceutical patent protection, signaling a renewed commitment to balancing patent rights with public access to medicines. In its ruling to Case No. 255/PUU-XXIII/2025, the court partially granted a petition for judicial review of Law No. 65 of 2024, which had amended the country’s Patent Law, and ordered the restoration of a provision that had excluded certain pharmaceutical inventions from patentability. The decision took effect immediately upon its pronouncement at the court’s plenary session on August 28, 2026. Background The petition challenged the removal of article 4(f) from Law No. 13 of 2016 concerning Patents (Patent Law), as amended by Law No. 65 of 2024. Article 4(f) had excluded from patentability certain inventions relating to new uses of known substances. The petitioners argued that removing this provision would open the door to patent protection for second medical use inventions and facilitate patent evergreening—practices that can extend exclusivity periods, delay generic market entry, and reduce public access to affordable medicines. The petitioners included several patient advocacy and public-interest organizations: the Indonesian Dialysis Patients Community Association, the Indonesian Association of Drug Abuse Victims (PKNI), the Indonesian Pulmonary Hypertension Foundation (YHPI), the Rekat Peduli Indonesia Foundation, and the Indonesian Positive Women’s Association (IPPI), along with the Indonesia for Global Justice Association and four individual petitioners. The petitioners also challenged the constitutionality of the phrase “interested party” in article 70(1) of the Patent Law, arguing that it should be construed expressly to clarify who has standing to appeal a decision to grant a patent before the Board of Patent Appeal, and to allow a broader range of parties—such as patent holders, licensees, consumer organizations, prosecutors, aggrieved third parties, and others who may suffer direct or indirect harm from the grant of a patent—to
September 2, 2026
Thailand and China have a longstanding and significant trade relationship, which increasingly extends to e-commerce and digitally enabled supply chains. While these channels create new opportunities for businesses to reach consumers across borders, their growth also brings greater exposure to intellectual property (IP) infringement across jurisdictions and online platforms. Effective cooperation between the two countries’ enforcement authorities has therefore become increasingly important. To strengthen cooperation in this area, Thailand and China signed a memorandum of understanding (MOU) on IP enforcement in Beijing on July 20, 2026, during the Thai prime minister’s official visit to China. Officially titled “Memorandum of Understanding Between the State Administration for Market Regulation of the People’s Republic of China and the Ministry of Commerce of the Kingdom of Thailand on Cooperation in the Field of Intellectual Property Enforcement,” the MOU forms part of a broader bilateral agenda covering industrial and supply chains, participation by micro, small, and medium-sized enterprises (MSMEs), cooperation associated with the ASEAN–China Free Trade Area 3.0, and progress on the registration of Thai geographical indications in China. The MOU establishes a bilateral framework for cooperation and coordination in five broad areas: Strengthening dialogue in IP enforcement; Enhancing information sharing; Facilitating the enforcement of IP rights in cases arising in the parties’ domestic markets and on online platforms, in accordance with their respective domestic laws; Promoting cooperation in IP enforcement training and human resource development; and Undertaking other cooperation activities agreed upon by both sides. The Department of Intellectual Property (DIP) will serve as the principal coordinating agency for Thailand, while the Bureau of Law Enforcement and Inspection in China’s State Administration for Market Regulation (SAMR) will serve in that role for China. The framework is particularly relevant to the growth of e-commerce, as it covers infringement in the domestic markets and on